News
Alexion begins multinational registration trials of eculizumab to treat...
US-based Alexion Pharmaceuticals has started a single, multinational, placebo-controlled trial designed to assess the safety and efficacy of eculizumab (Soliris) in patients with relapsing neuromyelitis...
News
NICE recommends afatinib for treatment of lung cancer
The National Institute for Health and Care Excellence (NICE) in the UK has issued its final health technology appraisal recommending afatinib as a first-line treatment...
News
Pfizer confirms £60bn bid interest in AstraZeneca
US-based drug maker Pfizer has confirmed that it has contacted AstraZeneca seeking to renew discussions over a possible £60bn takeover. The discussions...
News
Eli Lilly’s Cyramza becomes first FDA-approved gastric cancer drug
Eli Lilly has obtained US Food and Drug Administration approval for its Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric...
News
Abbvie starts Phase III trial of lung cancer drug...
US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) polymerase (PARP) inhibitor 'veliparib (ABT-888)'...
News
Roche Signs Licensing Agreement with Sysmex Inostics GmbH for...
Pleasanton, CA, USA, 21 February 2014 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a licensing agreement with Sysmex Inostics GmbH for its emPCR...
News
Nuevolution Announces License Agreement with Merck
Copenhagen, Denmark, February 21, 2014 - Today announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.